Assisted intelligence for intensive care
Intensive care is the most data-rich environment in any hospital, and with high volumes of high-fidelity clinical data it is an impeccable location to apply AI. With AlgoDx’s technology, we enable early detection of patient deterioration by augmenting healthcare provider clinical decision-making.
Equipping the ICU with cutting-edge solutions
In a data-rich environment such as the intensive care unit, some signs of patient deterioration can be difficult to spot in time.
The AlgoDx product portfolio includes machine learning algorithms for the prediction of conditions such as acute kidney injury (AKI), intended to assist clinical decision making in intensive care.
AKI is recognized as a major global public health concern, leading to increased morbidity and mortality, with associated high financial health care costs and major social impact.
Bringing clinically-validated AI to outpatients
Although our focus is intensive and critical care, we stand behind the hypothesis that data and AI based predictions can be used to dramatically improve outpatient care in specific diagnoses.
This is why we have partnered up with Takeda Pharmaceuticals in a scientific consortium looking to improve the outpatient experience for patients suffering from inflammatory bowel disease.
In this context, AlgoDx brings AI and regulatory expertise, with the goal to develop medical software that improves patient outcomes.